APA (7th ed.) Citation

D, S., MP, L., ML, P., A, E., A, D., C, B., . . . F, M. (2025). Clinical utility of pembrolizumab in the management of orbital recurrence of uveal melanoma: Case report. American journal of ophthalmology case reports, 40, 102473. https://doi.org/10.1016/j.ajoc.2025.102473

Chicago Style (17th ed.) Citation

D, Strianese, et al. "Clinical Utility of Pembrolizumab in the Management of Orbital Recurrence of Uveal Melanoma: Case Report." American Journal of Ophthalmology Case Reports 40 (2025): 102473. https://doi.org/10.1016/j.ajoc.2025.102473.

MLA (9th ed.) Citation

D, Strianese, et al. "Clinical Utility of Pembrolizumab in the Management of Orbital Recurrence of Uveal Melanoma: Case Report." American Journal of Ophthalmology Case Reports, vol. 40, 2025, p. 102473, https://doi.org/10.1016/j.ajoc.2025.102473.